Symbiotec Pharmalab's ₹1,757-crore IPO opened for subscription today, Aug 24, with investors closely tracking its grey market premium. The pharma company has fixed a price band of ₹938-₹988 per share, with the issue closing on Aug 27. Proceeds from the fresh issue will support debt repayment and corporate purposes, while existing investors are offering shares.
Business
₹1,757-Crore Symbiotec Pharmalab IPO Opens Today
